Arcutis Biotherapeutics I... (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

14.70

-0.21 (-1.41%)

At close: May 01, 2025, 3:59 PM

14.65

-0.34%

Pre-market: May 02, 2025, 04:33 AM EDT

Arcutis Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	196.54M	59.61M	3.69M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	19.13M	4.99M	754K	763K	455K	195K	n/a	n/a
Gross Profit	177.41M	54.62M	2.93M	-763K	-455K	-195K	n/a	n/a
Operating Income	-128.4M	-241.1M	-301.63M	-206.53M	-136.65M	-43.13M	-19.73M	-4.11M
Interest Income	n/a	n/a	9.83M	173K	967K	1.14M	n/a	n/a
Pretax Income	-139.39M	-259.03M	-311.46M	-206.36M	-135.68M	-42M	-19.25M	-4.98M
Net Income	-140.04M	-262.14M	-321.29M	-205.9M	-135.68M	-42M	-19.25M	-4.98M
Selling & General & Admin	229.39M	185.15M	122.12M	60.97M	21.34M	6.61M	1.79M	695K
Research & Development	76.42M	110.58M	182.44M	145.56M	115.31M	36.52M	17.94M	3.41M
Other Expenses	n/a	n/a	5.82M	173K	967K	1.14M	480K	-872K
Operating Expenses	305.81M	295.72M	304.56M	206.53M	136.65M	43.13M	19.73M	4.11M
Interest Expense	27.17M	29.71M	15.65M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	324.94M	300.71M	305.31M	206.53M	136.65M	43.13M	19.73M	4.11M
Income Tax Expense	647K	3.11M	9.83M	-454K	-84.3K	23.14K	-480K	-4.11M
Shares Outstanding (Basic)	120.96M	69.31M	55.03M	49.41M	35.67M	38.09M	36.24M	36.24M
Shares Outstanding (Diluted)	120.96M	69.31M	55.03M	49.41M	35.67M	38.09M	36.24M	36.24M
EPS (Basic)	-1.16	-3.78	-5.84	-4.17	-3.8	-1.1	-0.53	-0.14
EPS (Diluted)	-1.16	-3.78	-5.84	-4.17	-3.8	-1.1	-0.53	-0.14
EBITDA	-109.63M	-227.43M	-294.55M	-205.59M	-135.22M	-41.8M	480K	-872K
EBIT	-112.22M	-229.31M	-295.81M	-206.36M	-136.65M	-43.13M	-19.25M	-4.98M
Depreciation & Amortization	2.6M	1.88M	1.25M	763K	455K	195K	19.73M	4.11M